- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba, Medcon forge alliance
Toshiba Medical Systems Europe has established a partnership with Medcon Ltd. The two firms hope the alliance will help each company develop and market advanced digital angiographic site maps and integrated connectivity products. With the partnership,
Toshiba Medical Systems Europe has established a partnership with Medcon Ltd. The two firms hope the alliance will help each company develop and market advanced digital angiographic site maps and integrated connectivity products. With the partnership, TMSE of Zoetermeer, the Netherlands, adds Medcons cardiac network and archive offerings to its Infinix monoplane and biplane angiographic product line. Medcons products include telecardiology with voice overlay, as well as the ability to publish cardiac images on both an intranet and the Internet.
TMSE and Medcon have already won contracts with hospitals in six European sites, including the Great Ormond Street Hospital for Children in London, the Victoria General Hospital in Blackpool, U.K., and the Catholic University Hospital in Rome. The two firms emphasized that their alliance doesnt interfere with the activities of Medcons established dealers.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
